Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-055116

President, R&D sold 9,817 shares at an average $22.53 ($221,138)

  • President, R&D acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-28 Sale : show line 1 in the form −1,817 $21.54 $39,138 86,866 D
2022-11-01 Exercise or conversion : show line 2 in the form +8,000 $4.12 $32,960 94,866 D
2022-11-01 Sale : show line 3 in the form −8,000 $22.75 $182,000 86,866 D
Open-market sales · 9,817 sh · avg $22.53 · $221,138

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-01 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −8,000 93,456 D
Loading xslF345X03/doc4.xml…